WebJan 10, 2024 · The treatment, developed by SaNOtize Research and Development Corp. based in Vancouver, Canada, co-founded by Israeli Gilly Regev, proved 99.9% effective in killing the coronavirus in independent lab tests at Utah State University’s Antiviral Research Institute.. Get The Jewish News Daily Edition by email and never miss our top stories … WebJan 13, 2024 · Dr Gilly Regev is the CEO of Canada-based SaNOtize, whose Nitric Oxide Nasal Spray proved 99.9 per cent effective in independent lab tests at Utah State …
DR. GILLY REGEV: Rediscovering the Forgotten Nitric Oxide
WebGilly Regev, PhD, is cofounder and CEO of SaNOtize Research and Development Corp. a fast-growing Canadian company focused on addressing common topical infections … WebGilly Regev-Shoshani Consumption of polyphenols is associated with health promotion through diet, although many are poorly absorbed in animals and humans alike. Lipid peroxides may reach the ... greater jasper consolidated schools address
WebSaNOtize's CEO, Gilly Regev is featured in Medium's series, "Why We Need More Women Founders," where she discusses the story of SaNOtize, being a woman in biotech, and the challenges she overcame ... WebApr 22, 2024 · Dr. Gilly Regev, PhD. Dr Regev is a skilled entrepreneur with over 10 years of experience in anti-infectious research and product development. Her formal training is in analytical and bioanalytical chemistry. Gilly completed her Ph.D. at the Hebrew University of Jerusalem in 2004. Gilly served as the CSO of Bovicor, an animal health company ... WebFeb 21, 2024 · In an interaction with Fortune India, SaNOtize CEO and co-founder Gilly Regev mentions the company's anti-coronavirus nasal spray holds an edge over antiviral pills as it can be used daily, something which is not possible with the latter option. The spray, which uses nitric oxide to kill the virus, can reduce the viral load by 99% in 48 hours. flinstones i nut in his cereal